BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29198224)

  • 1. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.
    Krasnopero D; Asante-Korang A; Jacobs JP; Stapleton S; Carapellucci J; Dotson M; Stapleton G
    Cardiol Young; 2018 Mar; 28(3):471-475. PubMed ID: 29198224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use].
    Berends M; van Bokhoven MM; van de Luijtgaarden A; Bellersen LB; van Hoesel QC; van Herpen CM
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2088-92. PubMed ID: 18837186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from anthracycline-induced cardiomyopathy with biventricular assist and valve repairs: A case report and literature review.
    Takami Y; Hoshino N; Kato Y; Sakurai Y; Amano K; Higuchi Y; Tochii M; Ishida M; Ishikawa H; Takagi Y; Ozaki Y
    Int J Artif Organs; 2018 Jul; 41(7):413-417. PubMed ID: 29806528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
    Mort MK; Sen JM; Morris AL; DeGregory KA; McLoughlin EM; Mort JF; Dunn SP; Abuannadi M; Keng MK
    J Oncol Pharm Pract; 2020 Apr; 26(3):680-687. PubMed ID: 31500517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titanium Plug Closure after HeartWare Ventricular Assist Device Explantation in a 15-Year-Old Girl: First U.S. Experience.
    Lara DA; Jeewa A; Elias BA; McCullum EO; Denfield SW; Dreyer WJ; Adachi I
    Tex Heart Inst J; 2017 Feb; 44(1):66-69. PubMed ID: 28265217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of left ventricular assist device application for chemotherapy-related cardiomyopathy caused by trastuzumab and anthracycline.
    Inui T; Kohno H; Matsuura K; Ueda H; Tamura Y; Watanabe M; Inage Y; Yakita Y; Matsumiya G
    J Artif Organs; 2020 Sep; 23(3):270-274. PubMed ID: 31897739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure.
    Appel JM; Sander K; Hansen PB; Møller JE; Krarup-Hansen A; Gustafsson F
    Congest Heart Fail; 2012; 18(5):291-4. PubMed ID: 22521037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.
    Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
    Tex Heart Inst J; 2015 Apr; 42(2):124-30. PubMed ID: 25873821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of chronic anthracycline-induced heart failure with support from a continuous-flow left ventricular assist device.
    Khan N; Husain SA; Husain SI; Khalaf N; George J; Raissi F; Segura AM; Kar B; Bogaev RC; Frazier OH
    Tex Heart Inst J; 2012; 39(4):554-6. PubMed ID: 22949777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute chemotherapy-induced cardiomyopathy treated with intracorporeal left ventricular assist device in an 8-year-old child.
    Schweiger M; Dave H; Lemme F; Cavigelli-Brunner A; Romanchenko O; Heineking B; Hofmann M; Bürki C; Stiasny B; Hübler M
    ASAIO J; 2013; 59(5):520-2. PubMed ID: 23995994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
    Hiraiwa H; Okumura T; Shimizu S; Arao Y; Oishi H; Kato H; Kuwayama T; Yamaguchi S; Haga T; Yokoi T; Kondo T; Sugiura Y; Kano N; Watanabe N; Fukaya K; Furusawa K; Sawamura A; Morimoto R; Fujimoto K; Mutsuga M; Usui A; Murohara T
    Nagoya J Med Sci; 2020 Feb; 82(1):129-134. PubMed ID: 32273641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy.
    Kurihara C; Nishimura T; Nawata K; Kinoshita O; Hisagi M; Motomura N; Kyo S; Ono M
    J Artif Organs; 2011 Sep; 14(3):249-52. PubMed ID: 21534011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function.
    Farrar DJ; Holman WR; McBride LR; Kormos RL; Icenogle TB; Hendry PJ; Moore CH; Loisance DY; El-Banayosy A; Frazier H
    J Heart Lung Transplant; 2002 May; 21(5):516-21. PubMed ID: 11983540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
    Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
    Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It keeps on turning: Effects of prolonged long-term left ventricular assist device support as a bridge to heart transplantation.
    Schmack B; Grossekettler L; Zeriouh M; Weymann A; Mohite P; Koch A; Ruhparwar A; Simon AR; Sabashnikov A; Popov AF
    Int J Artif Organs; 2019 Feb; 42(2):65-71. PubMed ID: 30580668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridge to recovery with a thoratec biventricular assist device for postpartum cardiomyopathy.
    Zimmerman H; Coelho-Anderson R; Smith R; Nolan P; Copeland J
    ASAIO J; 2010; 56(5):479-80. PubMed ID: 20613487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel application of a percutaneous left ventricular assist device as a bridge to transplant in a paediatric patient with severe heart failure due to viral myocarditis.
    Perry P; David E; Atkins B; Raff G
    Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):474-476. PubMed ID: 28040759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a biventricular assist device in the treatment of acute doxorubicin-induced cardiotoxicity.
    Swartz MF; Fink GW; Carhart RL
    Congest Heart Fail; 2004; 10(4):197-9. PubMed ID: 15314480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.